Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders is a research paper published in RNA (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: HG004659
NIH
Grant: NS103172
NIH
Grant: NS112654
NHGRI NIH HHS
Grant: R01 HG004659
NINDS NIH HHS
Grant: R01 NS103172
NINDS NIH HHS
Grant: F32 NS112654
National Institutes of Health
Grant: 5R01HG004659-08
Functional RNA elements in the human genome
National Institutes of Health
Grant: 5R01NS103172-03
Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/Cas
National Institutes of Health
Grant: 5F32NS112654-02
Development of RNA-Directed Therapeutics for Myotonic Dystrophy Type 1 Neuropathology
Allen Distinguished Investigator Award
a University of California President's Postdoctoral Fellowship
a Paul G. Allen Frontiers Group advised grant of the Paul G. Allen Foundation
Biomedical Research Fellowship from the Hartwell Foundation
National Institutes of Health
Fields of Study
MeSH Terms
Keywords